Inhalation Sciences receives new order worth 292 KEUR from Aquilon Pharma
(Stockholm, 18 December 2020) Innovative inhalation pharmaceutical technology company Aquilon Pharma, based in Belgium, has signed a purchase order for ISAB’s high-precision R&D system PreciseInhale[®], plus its Nose-Only and Intratracheal Exposure Modules. The combined value of the order is 292 KEUR.Aquilon Pharma, originally founded as a spinout from the University of Liège, Belgium, has an innovative portfolio of new formulations that significantly improves the efficacy of inhaled drugs for asthma and COPD (Chronic Pulmonary Obstructive disorder). Strongly focused on precision and